Who owns the CAMBRIDGE BIOMEDICAL trademark?

The CAMBRIDGE BIOMEDICAL trademark is owned by Cambridge Biomedical Inc..

What class is the CAMBRIDGE BIOMEDICAL trademark registered in?

The CAMBRIDGE BIOMEDICAL trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for CAMBRIDGE BIOMEDICAL?

The USPTO serial number for CAMBRIDGE BIOMEDICAL is 77742297.

What is the registration number for CAMBRIDGE BIOMEDICAL?

CAMBRIDGE BIOMEDICAL is registered under USPTO registration number 3812894.

CAM

USPTO Trademark Record

REGISTERED

CAMBRIDGE BIOMEDICAL

SN 77742297·Reg 3812894·Filed May 21, 2009

Owner Cambridge Biomedical Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

CAMBRIDGE BIOMEDICAL (Serial No. 77742297), Registration No. 3812894, is a registered US trademark filed on May 21, 2009 by Cambridge Biomedical Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

Section 8/9 declaration window: July 08, 2030

Mark Intelligence

CAMBRIDGE BIOMEDICAL (Reg. #3812894) is a registered US trademark that has been protecting its owner, Cambridge Biomedical Inc., since 2009. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 21, 2009

SERIAL

77742297

REG#

3812894

REGISTERED

Jul 06, 2010

Owner

Applicant

Cambridge Biomedical Inc.

Entity

Corporation

State

Address

1320 Soldiers Field Road, Boston, MA, 02135

Country

Attorney

NameAndrew J. Ferren

Law firm

Andrew J. Ferren GOULSTON & STORRS PC

Docket

12399.0002

Address

400 Atlantic Avenue, BOSTON, MA 02110-3333, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateMay 21, 2009

Serial Number77742297

Registration No.3812894

Registration DateJul 06, 2010

Status DateJun 12, 2020

Published for OppositionApr 20, 2010

Next RenewalJuly 08, 2030

Mark TypeDesign with words

Attorney Docket12399.0002

Status DescriptionLive and registered, renewed

Filing Signals

FILED

2009

YEARS AGO

17y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jan 13, 2009

First use in commerce: May 18, 2009

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Jan 13, 2009

First use in commerce: May 18, 2009

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

42 events

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

Jun 12, 2020

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jun 12, 2020

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jun 12, 2020

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Jun 12, 2020

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

May 14, 2020

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

May 11, 2020

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 8 & 9 RECEIVED

Mar 04, 2020

TEAS SECTION 8 & 9 RECEIVED

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Jul 06, 2019

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Sep 17, 2016

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Sep 17, 2016

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Sep 17, 2016

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Jul 11, 2016

TEAS SECTION 8 & 15 RECEIVED

REGISTERED-PRINCIPAL REGISTER

Jul 06, 2010

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Apr 20, 2010

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 20, 2010

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 13, 2010

LAW OFFICE PUBLICATION REVIEW COMPLETED

EXAMINERS AMENDMENT -WRITTEN

Mar 11, 2010

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 11, 2010

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 11, 2010

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 11, 2010

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 11, 2010

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Mar 11, 2010

ASSIGNED TO LIE

NON-FINAL ACTION WRITTEN

Mar 08, 2010

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 08, 2010

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 08, 2010

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 09, 2010

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 09, 2010

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 08, 2010

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Feb 05, 2010

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 05, 2010

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 05, 2010

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO LIE

Jan 02, 2010

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 02, 2010

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 02, 2010

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Dec 17, 2009

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Aug 27, 2009

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 27, 2009

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 27, 2009

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 20, 2009

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE MAILED

May 27, 2009

NOTICE OF DESIGN SEARCH CODE MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 26, 2009

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 25, 2009

NEW APPLICATION ENTERED

CAMBRIDGE BIOMEDICAL

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Cambridge Biomedical Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Andrew J. Ferren

Resources

Company